Olivia Rastoin

815 total citations · 1 hit paper
11 papers, 570 citations indexed

About

Olivia Rastoin is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Olivia Rastoin has authored 11 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Olivia Rastoin's work include Pancreatic and Hepatic Oncology Research (2 papers), Renal cell carcinoma treatment (2 papers) and Immune cells in cancer (2 papers). Olivia Rastoin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Renal cell carcinoma treatment (2 papers) and Immune cells in cancer (2 papers). Olivia Rastoin collaborates with scholars based in France, Monaco and United Kingdom. Olivia Rastoin's co-authors include Magali Bébien, Christophe Verthuy, Toby Lawrence, Olympia Papantonopoulou, Anders Etzerodt, Juan Rodríguez‐Vita, Thien‐Phong Vu Manh, Marc Dalod, Pieter Goossens and Joachim L. Schultze and has published in prestigious journals such as Cell Metabolism, International Journal of Molecular Sciences and Biomacromolecules.

In The Last Decade

Olivia Rastoin

11 papers receiving 565 citations

Hit Papers

Membrane Cholesterol Efflux Drives Tumor-Associated Macro... 2019 2026 2021 2023 2019 100 200 300

Peers

Olivia Rastoin
Arwin Groenewoud Netherlands
Eileen L. Heinrich United States
Shan M. Chin United States
Colin G. Buss United States
Olivia Rastoin
Citations per year, relative to Olivia Rastoin Olivia Rastoin (= 1×) peers Yulei Chen

Countries citing papers authored by Olivia Rastoin

Since Specialization
Citations

This map shows the geographic impact of Olivia Rastoin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Rastoin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Rastoin more than expected).

Fields of papers citing papers by Olivia Rastoin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Rastoin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Rastoin. The network helps show where Olivia Rastoin may publish in the future.

Co-authorship network of co-authors of Olivia Rastoin

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Rastoin. A scholar is included among the top collaborators of Olivia Rastoin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Rastoin. Olivia Rastoin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Dufies, Maeva, Olivia Rastoin, Letícia Christina Pires Gonçalves, et al.. (2024). A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELR+CXCL-CXCR1/2 Pathway Inhibitor. ACS Medicinal Chemistry Letters. 15(6). 845–856. 1 indexed citations
2.
Bovio, Elena, Olivia Rastoin, Maeva Dufies, et al.. (2023). New Phenylspirodrimanes from the Sponge-Associated Fungus Stachybotrys chartarum MUT 3308. Marine Drugs. 21(3). 135–135. 8 indexed citations
3.
Saâda-Bouzid, Esma, Damien Ambrosetti, Olivia Rastoin, et al.. (2022). Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma. Cell Reports Medicine. 3(9). 100659–100659. 23 indexed citations
4.
Ambrosetti, Damien, Julien Boyer, Alexandre Bozec, et al.. (2021). The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy. Theranostics. 11(19). 9571–9586. 26 indexed citations
5.
Ambrosetti, Damien, Michael Coutts, M. Durand, et al.. (2021). Cancer‐associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti‐angiogenic therapy. British Journal of Urology. 129(1). 80–92. 35 indexed citations
6.
Montemagno, Christopher, Delphine Borchiellini, Olivia Rastoin, et al.. (2020). Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma. OncoImmunology. 9(1). 1846901–1846901. 35 indexed citations
7.
Rastoin, Olivia, Gilles Pagès, & Maeva Dufies. (2020). Experimental Models in Neovascular Age Related Macular Degeneration. International Journal of Molecular Sciences. 21(13). 4627–4627. 32 indexed citations
8.
Goossens, Pieter, Juan Rodríguez‐Vita, Anders Etzerodt, et al.. (2019). Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression. Cell Metabolism. 29(6). 1376–1389.e4. 347 indexed citations breakdown →
9.
Goossens, Pieter, Juan Rodríguez‐Vita, Anders Etzerodt, et al.. (2018). Tumor-Induced Cholesterol Efflux from Macrophages Drives IL-4 Mediated Reprogramming and Tumor Progression. SSRN Electronic Journal. 2 indexed citations
10.
Habbeddine, Mohamed, Christophe Verthuy, Olivia Rastoin, et al.. (2017). Receptor Activator of NF-κB Orchestrates Activation of Antiviral Memory CD8 T Cells in the Spleen Marginal Zone. Cell Reports. 21(9). 2515–2527. 26 indexed citations
11.
Abelha, Thais Fedatto, Olivia Rastoin, Richard D. Harvey, et al.. (2015). Surface Chemistry of Photoluminescent F8BT Conjugated Polymer Nanoparticles Determines Protein Corona Formation and Internalization by Phagocytic Cells. Biomacromolecules. 16(3). 733–742. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026